We are live on ! Find out more
Cerity Partners

Cerity Partners Portfolio holdings

AUM $70.8B
1-Year Est. Return 21.68%
This Fund
S&P 500
This Quarter Est. Return
+9.59%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
AUM
$6.57B
AUM Growth
+$2.03B
Cap. Flow
+$2.45B
Cap. Flow %
37.3%
Top 10 Hldgs %
34.2%
Holding
1,058
New
376
Increased
498
Reduced
106
Closed
39

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$41.1M
2
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$35.2M
3
DIS icon
Walt Disney
DIS
+$31.4M
4
UNP icon
Union Pacific
UNP
+$30.4M
5
UNH icon
UnitedHealth
UNH
+$26M

Sector Composition

Rank Sector Weight
1 Technology 16.2%
2 Industrials 8.96%
3 Financials 8.9%
4 Healthcare 8.72%
5 Consumer Discretionary 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITUB icon
1001
Itaú Unibanco
ITUB
$91.4B
$48K ﹤0.01%
+15,073
New +$54.3K
LAB icon
1002
Standard BioTools
LAB
$310M
$47K ﹤0.01%
12,110
KOS icon
1003
Kosmos Energy
KOS
$1.46B
$45K ﹤0.01%
+12,806
New +$46K
CIG icon
1004
CEMIG Preferred Shares
CIG
$6.09B
$42K ﹤0.01%
+28,776
New +$41.4K
BKCC
1005
DELISTED
BlackRock Capital Investment Corporation
BKCC
$40K ﹤0.01%
+10,189
New +$42.6K
IVC
1006
DELISTED
Invacare Corporation
IVC
$38K ﹤0.01%
13,931
KLDO
1007
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$38K ﹤0.01%
15,950
-50
-0.3% -$204
ABEV icon
1008
Ambev
ABEV
$47B
$34K ﹤0.01%
+10,919
New +$31.3K
RIGL icon
1009
Rigel Pharmaceuticals
RIGL
$704M
$33K ﹤0.01%
1,230
VEON icon
1010
VEON
VEON
$3.59B
$19K ﹤0.01%
+422
New +$20.6K
BRMK.WS
1011
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$19K ﹤0.01%
213,500
DFAT icon
1012
Dimensional US Targeted Value ETF
DFAT
$14.6B
$18K ﹤0.01%
+368,607
New +$17.3M
CATX icon
1013
Perspective Therapeutics
CATX
$333M
$16K ﹤0.01%
4,000
SNDL icon
1014
Sundial Growers
SNDL
$336M
$7K ﹤0.01%
+1,245
New +$8.15K
CSCI
1015
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$7K ﹤0.01%
200
ZOM
1016
DELISTED
Zomedica Corp.
ZOM
$6K ﹤0.01%
20,000
UAMY icon
1017
United States Antimony
UAMY
$785M
$5K ﹤0.01%
+10,000
New +$7.36K
DLHC icon
1018
DLH Holdings
DLHC
$74.3M
$3K ﹤0.01%
+128,314
New +$1.94M
MQ icon
1019
Marqeta
MQ
$1.86B
$3K ﹤0.01%
+11,277
New +$1.01M
AI icon
1020
C3.ai
AI
$1.39B
-8,040
Closed -$373K
ARKW icon
1021
ARK Web x.0 ETF
ARKW
$1.63B
-2,804
Closed -$389K
BNL icon
1022
Broadstone Net Lease
BNL
$4.34B
-21,298
Closed -$528K
BYND icon
1023
Beyond Meat
BYND
$287M
-6,607
Closed -$695K
CLOV icon
1024
Clover Health Investments
CLOV
$2.28B
-12,307
Closed -$91K
COR icon
1025
Cencora
COR
$60.7B
-3,774
Closed -$451K

Similar funds

Cerity Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Cerity Partners held 1,058 positions worth $6.57B, up 45% from $4.55B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Cerity Partners deployed $2.45B of net new capital in Q4 2021, opening 376 new positions and adding to 498 existing holdings. Its largest new stake was iShares Expanded Tech Sector ETF: 1,163,598 shares worth $72.7M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Visa, an estimated $41.1M trimmed.

  • Cerity Partners's largest Q4 2021 buy was iShares Expanded Tech Sector ETF: 1,163,598 shares worth $72.7M.
  • Cerity Partners added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $375M increase.
  • Cerity Partners's biggest Q4 2021 reduction was Visa, cutting an estimated $41.1M.
  • Cerity Partners fully exited Roblox in Q4 2021, selling an estimated $14.8M.
  • Cerity Partners's ten largest holdings make up 34% of its $6.57B portfolio in Q4 2021.
  • Cerity Partners opened 376 new positions and closed 39 in Q4 2021.
  • Cerity Partners's portfolio value rose 45% quarter-over-quarter to $6.57B.

Based on Cerity Partners's 13F filing for Q4 2021, filed 14 Feb 2022.